BIO IMAGING TECHNOLOGIES INC
10KSB, EX-27, 2000-12-20
MEDICAL LABORATORIES
Previous: BIO IMAGING TECHNOLOGIES INC, 10KSB, EX-23.1, 2000-12-20
Next: ADVANCED FINANCIAL INC, 8-K, 2000-12-20



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE AUDITED
FINANCIAL STATEMENTS INCLUDED IN THE REGISTRANT'S FROM 10-KSB FOR THE YEAR ENDED
SEPTEMBER 30, 2000  AND  IS  QUALIFIED  IN  ITS  ENTIRETY  BY REFERENCE  TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                         0000822418
<NAME>                        Bio-Imaging Technologies, Inc.
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. Dollars

                              <S>              <C>
<PERIOD-TYPE>                 YEAR
<FISCAL-YEAR-END>                              SEP-30-2000
<PERIOD-START>                                 OCT-01-1999
<PERIOD-END>                                   SEP-30-2000
<EXCHANGE-RATE>                                1
<CASH>                                         491,048
<SECURITIES>                                   0
<RECEIVABLES>                                  1,692,457
<ALLOWANCES>                                   65,000
<INVENTORY>                                    0
<CURRENT-ASSETS>                               2,352,706
<PP&E>                                         3,209,906
<DEPRECIATION>                                 1,917,562
<TOTAL-ASSETS>                                 3,906,812
<CURRENT-LIABILITIES>                          2,408,944
<BONDS>                                        164,139
                          0
                                    104
<COMMON>                                       1,944
<OTHER-SE>                                     1,331,681
<TOTAL-LIABILITY-AND-EQUITY>                   3,906,812
<SALES>                                        0
<TOTAL-REVENUES>                               5,772,443
<CGS>                                          0
<TOTAL-COSTS>                                  3,619,343
<OTHER-EXPENSES>                               2,753,510
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             92,021
<INCOME-PRETAX>                                (692,431)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (692,431)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (692,431)
<EPS-BASIC>                                    (0.09)<F1>
<EPS-DILUTED>                                  (0.09)<F2>
<FN>
<F1>  This  amount  represents Basic Earnings  per Share in accordance  with the
      requirements  of  Statement of  Financial Accounting  Standards No.  128 -
      "Earnings per Share".
<F2>  This  amount represents Diluted  Earnings per Share in accordance with the
      requirements  of  Statement of Financial  Accounting Standards  No.  128 -
      "Earnings per Share".
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission